• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. PROLENE POLYPROPYLENE SUTURE UNKNOWN PRODUCT; SUTURE, NONABSORBABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. PROLENE POLYPROPYLENE SUTURE UNKNOWN PRODUCT; SUTURE, NONABSORBABLE Back to Search Results
Device Problem Insufficient Information (3190)
Patient Problems Hemorrhage/Bleeding (1888); Not Applicable (3189)
Event Type  Injury  
Manufacturer Narrative
(b)(4).This report is related to a journal article, therefore no product will be returned for analysis and the batch history records cannot be reviewed as the lot number has not been provided.No specific patient information regarding events has been provided.If further details are received at the later date a supplemental medwatch will be sent.(b)(4).
 
Event Description
Title : midterm follow up in patients with reduction ascending aortoplasty the reduction ascending aortoplasty in patients with an aortic ectasia/dilatation is a common procedure during concomitant cardiac operations.The aim of the follow up study was to evaluate the possibility of re-dilatation and its complications.From january 1998 to 2010, a total of 124 patients (85 male and 39 female; mean age: 66.6 ± 12 years) with ectasia of the ascending aorta who had no further indication for an aortic replacement, underwent reduction ascending aortoplasty associated with dilatation and ectasia of the ascending aorta.From 2011 to 2012 the patients were asked to return for a follow-up echocardiography at the (b)(6) hospital.The mean preoperative diameter of the ascending aorta was 4.2 ± 0.6 cm.The patients risk profile was moderate (mean ef 51% ± 11%; euroscore 4.2 ± 2.1).The reduction ascending aortoplasty consisted of the direct resection of an oval section of the anterior wall of the ascending aorta.The aortotomy was then adjusted in 2 layers with prolene 4-0 suture material.Reported complications included secondary hemorrhage at the aortoplasty suture line (n-4) which required surgical intervention and progression of the aortic dilatation (n-4).It was concluded that the reduction ascending aortoplasty is a safe and effective treatment option in patients with dilated ascending aorta (<50 mm) or significant contraindications for aortic replacement.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROLENE POLYPROPYLENE SUTURE UNKNOWN PRODUCT
Type of Device
SUTURE, NONABSORBABLE
Manufacturer (Section D)
ETHICON INC.
p.o. box 151, route 22 west
somerville NJ 08876 0151
Manufacturer (Section G)
ETHICON INC.
Manufacturer Contact
darlene kyle
p.o. box 151, route 22 west
somerville, NJ 08876-0151
MDR Report Key7635945
MDR Text Key112366404
Report Number2210968-2018-73769
Device Sequence Number1
Product Code GAW
Combination Product (y/n)N
PMA/PMN Number
K133356
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 06/05/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 06/05/2018
Initial Date FDA Received06/25/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-